Business
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
Preliminary fourth quarter Revenue and Adjusted Revenue exceed previously announced guidance SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc.
About this update from Goodrx Holdings, Inc.
[{"type":"text","content":"\nPreliminary fourth quarter Revenue and Adjusted Revenue exceed previously announced guidance\n\n\n SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.\n\n\nFourth Quarter 2023\n\n\n\nRevenue1,2 and Adjusted Revenue1,2 expected to be in the range of $195 million to $197 million\n\n\n\nAdjusted EBITDA Margin2,3 expected to be in the upper end of previous guidance range provided on November 9, 2023\n\n\n\nFull Year 2023\n\n\n\nRevenue1,2 expected to be in the range of $749 million to $751 million\n\n\n\nAdjusted Revenue1,2 expected to be in the range of $759 million to $761 million\n\n\n\nAdjusted EBITDA Margin2,3 expected to be in the upper end of previous guidance range provided on November 9, 2023\n\n\n\n“We are encouraged by the preliminary fourth quarter results and the progress we continue to make against our priorities. There is exciting work underway and we expect to build on our accelerating momentum in 2024,” said Karsten Voermann, Chief Financial Officer. “While our line of sight into the first quarter is limited being only a few days in, we’re pleased with our initial trajectory. Based on our expectations today, we’re confident that first quarter and full year 2024 revenue and Adjusted Revenue4 will grow mid-single digit percentages year-over-year and Adjusted EBITDA Margin5 will be in the high twenty-percent range for both periods. We look forward to providing fulsome first quarter and 2024 guidance on our fourth quarter earnings call in February.”\n\n\nPreliminary Fourth Quarter and Full Year 2023 Financial Results\n\n\nFourth quarter and full year 2023 revenue and Adjusted Revenue1,2 is expected to exceed the November guidance range. Fourth quarter revenue and Adjusted Revenue1,2 is expected to be in the range of approximately $195 million to $197 million, an increase of approximately 6% to 7% year-over-year. Full year 2023 revenue1,2 is expected to be in the range of approximately $749 million to $751 million, a decrease of approximately 2% year-over-year. Full year 2023 Adjusted Revenue1,2 is expected to be in the range of approximately $759 million to $761 million, a decrease of approximately...